Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
TSC2 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
TSC2 target evaluation report generated from PatSnap MCP data, covering tuberin biology, mTORC1 regulation, asset landscape, clinical evidence, IP, and next-step strategy.
Latest Hotspot
8 min read
TSC1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
TSC1 target evaluation report generated from PatSnap MCP data, assessing TSC complex biology, mTORC1 regulation, clinical evidence, competition, IP, and R&D strategy.
Latest Hotspot
8 min read
RICTOR Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
RICTOR target evaluation report built from PatSnap Life Sciences MCP data, covering mTORC2 biology, validation gaps, competition, IP considerations, and R&D strategy.
Latest Hotspot
8 min read
RPTOR Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
RPTOR target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, clinical competition, IP and R&D strategy.
Latest Hotspot
8 min read
MTOR Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
MTOR target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, clinical competition, IP and R&D strategy.
Latest Hotspot
8 min read
PTEN Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
PTEN target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, clinical competition, IP and R&D strategy.
Latest Hotspot
8 min read
NF1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
NF1 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, clinical competition, IP and R&D strategy.
Latest Hotspot
8 min read
NRAS Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
NRAS target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, clinical competition, IP and R&D strategy.
Latest Hotspot
8 min read
HRAS Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
HRAS target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, clinical competition, IP and R&D strategy.
Latest Hotspot
8 min read
ARAF Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
ARAF target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, clinical competition, IP and R&D strategy.
Latest Hotspot
8 min read
RAF1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
RAF1 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, clinical competition, IP and R&D strategy.
Latest Hotspot
8 min read
MAP2K2 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
MAP2K2 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, clinical competition, IP and R&D strategy.